3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
1
Gynecologic
1
Conditions
Prostatic Neoplasms
3
Hematologic Neoplasms
2
Teratoma
1
Stroke
1
Pulmonary Disease, Chronic Obstructive
1
Neoplasms, Germ Cell and Embryonal
1
Neoplasms
1
Neoplasm Metastasis
1
Lymphoma, T-Cell
1
Lymphoma, Large-Cell, Anaplastic
1
Lymphoma
1
Lung Neoplasms
1
Leukemia, Myeloid, Acute
1
Kidney Failure, Chronic
1
Hepatitis B
1
Hematopoietic and Lymphatic System Neoplasm
1
Endometrial Clear Cell Adenocarcinoma
1
Endodermal Sinus Tumor
1
Diabetes Mellitus
1
Coronary Artery Disease
1
Colonic Neoplasms
1
Carcinoma, Embryonal
1
COVID-19
1
Breast Neoplasms
1
Anatomic Stage I Breast Cancer AJCC v8
1
Interventions
Radiotherapy
2
Radiation
2
Paclitaxel
2
Cisplatin
2
Carboplatin
2
Brachytherapy
2
Taxes
1
Standard of Care
1
Practice Guidelines as Topic
1
Platinum
1
1,2-diaminocyclohexaneplatinum II citrate
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 3
×
Endometrial Clear Cell Adenocarcinoma
×
Practice Guidelines as Topic
×
Clear all
NCT03422198
2025-12-12
SAVE
University of Utah
Phase 3
Recruiting
188 enrolled
15 charts